Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership12,310 shares
Ownership 0.01%
Fmr Llc ownership in MD / Pediatrix Medical Group, Inc.

2023-02-09 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,310 shares of Pediatrix Medical Group, Inc. (US:MD). This represents 0.014 percent ownership of the company. In their previous filing dated 2022-02-09 , Fmr Llc had reported owning 5,555,578 shares, indicating a decrease of -99.78 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2023-02-09 2023-02-09 13G/A 5,555,578 12,310 -99.78 0.01 -99.78
2022-02-09 2022-02-09 13G 3,876,210 5,555,578 43.33 6.43 55.29
2018-02-13 2018-02-13 13G/A 5,245,567 3,876,210 -26.11 4.14 -26.13
2017-02-14 2017-02-14 13G 5,245,567 5.60
2014-09-09 2014-09-09 13G/A 3,673,390 3.67
2014-02-14 2014-02-14 13G/A 8,823,953 8.77
2013-11-12 2013-11-12 13G/A 4,686,326 9.26
2013-02-14 2013-02-14 13G/A 7,198,654 14.45
2012-06-11 2012-06-11 13G/A 4,979,013 10.12
2012-02-14 2012-02-14 13G 4,191,512 8.57

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,267,434 -161,349 -6.64 48,500 -6.64 0.0005
2026-02-17 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,428,783 224,246 10.17 51,952 40.69 0.0026
2025-11-13 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,204,537 -209,500 -8.68 36,926 6.59 0.0019
2025-08-14 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,414,037 -492,421 -16.94 34,641 -17.74 0.0020
2025-05-12 2025-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,906,458 99 0.00 42,115 10.45 0.0027
2025-02-13 2024-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 2,906,359 2,896,518 29,433.17 38,131 33,348.25 0.0023
2024-11-13 2024-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 9,841 6,771 220.55 114 395.65 0.0000
2024-08-13 2024-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 3,070 -2,471 -44.59 23 -58.18 0.0000
2024-05-13 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 5,541 2,103 61.17 56 77.42 0.0000
2024-02-13 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 3,438 -4,558 -57.00 32 -69.31 0.0000
2023-11-13 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 7,996 -4,492 -35.97 102 -42.94 0.0000
2023-08-11 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 12,488 729 6.20 177 1.14 0.0000
2023-08-11 2023-03-31 13F/A-1 PEDIATRIX MEDICAL GROUP COM 58502B106 11,759 -551 -4.48 175 -3.85 0.0000
2023-05-11 2023-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 11,759 -551 175 0.0000
2023-02-13 2022-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 12,310 128 1.05 183 -9.45 0.0000
2022-11-10 2022-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 12,182 -3,071,762 -99.60 201 -99.69 0.0000
2022-08-12 2022-06-30 13F MEDNAX COM 58502B106 3,083,944 -423,645 -12.08 64,795 -21.33 0.0065
2022-05-13 2022-03-31 13F MEDNAX COM 58502B106 3,507,589 -2,047,989 -36.86 82,358 -45.52 0.0066
2022-02-14 2021-12-31 13F MEDNAX COM 58502B106 5,555,578 464,458 9.12 151,167 4.44 0.0112
2022-02-14 2021-09-30 13F/A-1 MEDNAX COM 58502B106 5,091,120 204,784 4.19 144,741 -1.75 0.0115
2021-11-15 2021-09-30 13F MEDNAX COM 58502B106 5,091,120 204,784 144,741 0.0115
2021-08-13 2021-06-30 13F MEDNAX COM 58502B106 4,886,336 588,474 13.69 147,323 34.58 0.0115
2021-05-14 2021-03-31 13F MEDNAX COM 58502B106 4,297,862 2,199,360 104.81 109,467 112.57 0.0093
2021-02-08 2020-12-31 13F MEDNAX COM 58502B106 2,098,502 409,544 24.25 51,497 87.29 0.0046
2020-11-13 2020-09-30 13F MEDNAX COM 58502B106 1,688,958 37,387 2.26 27,496 -2.64 0.0028
2020-08-24 2020-06-30 13F/A-1 MEDNAX COM 58502B106 1,651,571 71,290 4.51 28,241 53.53 0.0031
2020-08-13 2020-06-30 13F MEDNAX COM 58502B106 1,651,571 71,290 28,241 693.7987
2020-05-14 2020-03-31 13F MEDNAX COM 58502B106 1,580,281 -122,825 -7.21 18,395 -61.13 0.0025
2020-02-07 2019-12-31 13F MEDNAX COM 58502B106 1,703,106 -622,165 -26.76 47,329 -10.02 0.0052
2019-11-13 2019-09-30 13F MEDNAX COM 58502B106 2,325,271 363,264 18.51 52,597 6.25 0.0063
2019-08-13 2019-06-30 13F MEDNAX COM 58502B106 1,962,007 498,672 34.08 49,502 24.51 0.0058
2019-05-13 2019-03-31 13F MEDNAX COM 58502B106 1,463,335 -357,657 -19.64 39,759 -33.84 0.0048
2019-02-13 2018-12-31 13F MEDNAX COM 58502B106 1,820,992 -95,931 -5.00 60,094 -32.81 0.0082
2018-11-09 2018-09-30 13F MEDNAX COM 58502B106 1,916,923 -33,833 -1.73 89,444 5.94 0.0101
2018-08-10 2018-06-30 13F MEDNAX COM 58502B106 1,950,756 -647,106 -24.91 84,429 -41.58 0.0100
2018-05-14 2018-03-31 13F MEDNAX COM 58502B106 2,597,862 -1,278,139 -32.98 144,519 -30.23 0.0172
2018-02-12 2017-12-31 13F MEDNAX COM 58502B106 3,876,001 2,096,802 117.85 207,133 169.99 0.0243
2017-11-13 2017-09-30 13F MEDNAX COM 58502B106 1,779,199 -1,283,344 -41.90 76,719 -58.50 0.0093
2017-08-29 2017-06-30 13F/A-1 MEDNAX COM 58502B106 3,062,543 -2,251,038 -42.36 184,886 -49.85 0.0230
2017-08-11 2017-06-30 13F MEDNAX COM 58502B106 3,062,543 -2,251,038 184,886
2017-05-11 2017-03-31 13F MEDNAX COM 58502B106 5,313,581 68,581 1.31 368,656 5.44 0.0468
2017-02-10 2016-12-31 13F MEDNAX COM 58502B106 5,245,000 -352,248 -6.29 349,631 -5.71 0.0467
2016-11-14 2016-09-30 13F MEDNAX COM 58502B106 5,597,248 538,593 10.65 370,818 1.21 0.0494
2016-08-11 2016-06-30 13F MEDNAX COM 58502B106 5,058,655 -97,436 -1.89 366,399 9.97 0.0500
2016-05-16 2016-03-31 13F MEDNAX COM 58502B106 5,156,091 857,085 19.94 333,187 8.15 0.0461
2016-02-12 2015-12-31 13F MEDNAX COM 58502B106 4,299,006 710,974 19.82 308,067 11.81 0.0414
2015-11-10 2015-09-30 13F MEDNAX COM 58502B106 3,588,032 -133,499 -3.59 275,524 -0.10 0.0392
2015-08-25 2015-06-30 13F/A-1 MEDNAX COM 58502B106 3,721,531 337,252 9.97 275,803 12.39 0.0353
2015-08-13 2015-06-30 13F MEDNAX COM 58502B106 3,721,531 275,803
2015-05-14 2015-03-31 13F MEDNAX COM 58502B106 3,384,279 238,279 7.57 245,394 17.99 0.0313
2015-02-17 2014-12-31 13F MEDNAX COM 58502B106 3,146,000 80,684 2.63 207,983 23.77 0.0271
2014-11-14 2014-09-30 13F MEDNAX COM 58502B106 3,065,316 -1,849,808 -37.64 168,040 -41.21 0.0228
2014-08-14 2014-06-30 13F MEDNAX COM 58502B106 4,915,124 -3,113,921 -38.78 285,814 -42.57 0.0383
2014-05-15 2014-03-31 13F MEDNAX COM 58502B106 8,029,045 -387,571 -4.60 497,640 10.76 0.0691
2014-02-13 2013-12-31 13F MEDNAX COM 58502B106 8,416,616 3,676,038 77.54 449,279 -5.60 0.0635
2013-11-14 2013-09-30 13F MEDNAX COM 58502B106 4,740,578 -397,309 -7.73 475,954 1.15 0.0729
2013-09-24 2013-06-30 13F/A-1 MEDNAX COM 58502B106 5,137,887 5,137,887 470,527 0.0770
2013-08-14 2013-06-30 13F MEDNAX COM 58502B106 5,137,887 470,527 0.0770
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.